DYAI dyadic.com: שולי רווח נקי ממכירות

DYAI (dyadic.com) - סמל מסחרי של החברה

The revenue margin indicator on the GURU.Markets chart demonstrates the financial dynamics of Dyadic International (DYAI), where -226.90 serves as the current parameter value. The business aims to monetize the C1 fungal system through licenses to reduce biological product costs. Growth depends on platform scaling and the volume of partner payments. The ecosystem attracts veterinary contracts, while the FDA monitors product safety.

dyadic.com (DYAI) - שולי מכירות של החברה מ-04.07.2022 עד 19.11.2026

dyadic.com (DYAI) - פילוחי מדדים ודוחות פיננסיים

ניתוח כל מדדי החברה:Dyadic International
מוצרים מוגמרים של Dyadic International

A comparative asset analysis requires an evaluation of how efficiently revenue is converted into net income. This metric measures the profit margin after deducting all operating and tax expenses. For Dyadic International (DYAI), such resilience is ensured by licensing contracts that remain independent of macroeconomic cycles. This renders the biotech manufacturing business model shielded from GDP volatility. The trend in net profit margins allows for the real-time verification of the company's intrinsic value.